Delivery Order SPE2DB22D2006-SPE2DB23FV9JA
- Not listed
- This federal contract award, valued at $1,175.24, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 1,200,000 units of Bicillin L-A 2mL, a pharmaceutical product, to support military treatment programs and facilities. The contract is a firm fixed price delivery order and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite...
- This federal contract award, valued at $1,175.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,200,000 units of Bicillin L-A, a prescription medication, with an ultimate completion date of April 24, 2024. This is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 1,200,000 units of Bicillin L-A, a pharmaceutical product, with a ceiling value of $102,963.84. The contract is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
- This federal contract award, valued at $2,413.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has no set-aside designation, is a Delivery Order for the supply of 1,200,000 units of Bicillin L-A, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,175.24, is for the supply of 1,200,000 units of Bicillin L-A, a pharmaceutical product, with a performance period ending on July 30, 2024. This award is not associated with any set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
- This federal contract award, valued at $58,762.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,200,000 units of Bicillin L-A, a medication, with a performance period ending on March 20, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
- This federal contract award, valued at $1,578.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 1,200,000 units of Bicillin L-A, a 2ML antibiotic medication. The contract has an ultimate completion date of April 23, 2025 and is a firm fixed price arrangement. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $112,824.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 1,200,000 units of Bicillin L-A, a penicillin-based medication, with an ultimate completion date of August 28, 2024. This contract is not associated with any set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,525.75, is for the delivery of 1,200,000 units of Bicillin L-A, a 2ml injectable medication, with an ultimate completion date of October 17, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen, a for-profit organization registered in the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,559.68, is for the delivery of 1,200,000 units of Bicillin L-A, a specific pharmaceutical product, with a completion date of December 11, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB23FV9JADelivery Order
This federal contract award, valued at $2,157.12, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 1,200,000 units of Bicillin L-A, a pharmaceutical product, and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The contract is a delivery order against Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 4/26/23 |